MAPT and tauopathy: A separate study by Spatara et al. has proven that the activation of the UPR signaling pathway is absent in several models of tauopathies such as the SH-SY5Y cell line, 4R tau- and P301L tau-expressing HEK293 cells, or PS19 transgenic mice [52].